Skip to main content

Table 2 Availability of screening methods for neuromuscular diseases

From: Survey on patients’ organisations’ knowledge and position paper on screening for inherited neuromuscular diseases in Europe

Country Type of organisation Is PGD available? Includes NMD? Is PNS in place? Includes NMD? Is NBS in place? Includes NMD?
BE Disease specific Yes Yes Yes Yes Yes Yes
BG All NMD Yes Yes Yes Yes Yes Yes
CZ Disease specific No No Yes No Yes No
DK All NMD No No Yes No Yes No
FR Disease specific Yes Yes Yes Yes No No
FR All NMD Yes Yes Yes Yes Yes No
DE All NMD Yes Yes Yes Yes Yes No
GR All NMD Yes Yes Yes Yes Yes Yes
IT Disease specific No No Yes Yes Yes Yes
LU All NMD No No Yes No Yes No
NL All NMD Yes Yes No No Yes No
MK Disease specific No No Yes Yes No No
MK All NMD No No Yes Yes No No
PL All NMD No No Yes Yes Yes No
PT All NMD Yes No No No Yes No
RO Disease specific No No Yes No Yes No
RO Disease specific Yes Yes Yes Yes Yes Yes
RS Disease specific No No Yes No No No
ES All NMD No No No No No No
ES Disease specific No No Yes No Yes No
ES Disease specific No No Yes No Yes No
ES All NMD Yes Yes Yes Yes Yes Yes
ES Disease specific Yes Yes No No Yes Yes
ES Disease specific Yes Yes Yes Yes Yes Yes
ES All NMD Yes Yes Yes Yes Yes Yes
ES Disease specific No No Yes No No No
ES Disease specific Yes Yes Yes Yes Yes Yes
ES Disease specific No No No No Yes No
CH Disease specific No No No No Yes No
UK Disease specific Yes Yes Yes No Yes No
  1. Representation of the answers across countries and type of PO regarding the different screening techniques